Search research articles
Contact Us
Filters
Showing results (1-10 of 33) with videos related to
Page
of 4
Sort By:
Current Opinion in Urology
|
March 21, 2013
Novel chemotherapies in development for management of castration-resistant prostate cancer
Alok K Tewari, Daniel J George
The Journal of Clinical Investigation
|
November 13, 2013
Type III TGF-β receptor promotes FGF2-mediated neuronal differentiation in neuroblastoma
Erik H Knelson, Angela L Gaviglio, Alok K Tewari, et al.
JAMA Oncology
|
June 2, 2017
Interventions to Improve Oral Chemotherapy Safety and Quality: A Systematic Review
Jessica A Zerillo, Benjamin A Goldenberg, Ritesh R Kotecha, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 18, 2009
Genomic strategy for targeting therapy in castration-resistant prostate cancer
Prateek Mendiratta, Elahe Mostaghel, Justin Guinney, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 14, 2026
How to Optimize Treatment for Patients With Poor-Risk Testicular Cancer
Noah Richardson, Alok K Tewari, Patrizia Giannatempo, et al.
Genome Research
|
May 24, 2022
Profiling the quantitative occupancy of myriad transcription factors across conditions by modeling chromatin accessibility data
Kaixuan Luo, Jianling Zhong, Alexias Safi, et al.
The Prostate
|
November 27, 2024
Personalized Medicine: Leave no Patient Behind; Report From the 2024 Coffey-Holden Prostate Cancer Academy Meeting
Andrea K Miyahira, Marina Sharifi, Lisa N Chesner, et al.
The Prostate
|
November 30, 2012
Resveratrol worsens survival in SCID mice with prostate cancer xenografts in a cell-line specific manner, through paradoxical effects on oncogenic pathways
Joseph C Klink, Alok K Tewari, Elizabeth M Masko, et al.
European Urology
|
July 1, 2008
Satisfaction and regret after open retropubic or robot-assisted laparoscopic radical prostatectomy
Florian R Schroeck, Tracey L Krupski, Leon Sun, et al.
Biorxiv : the Preprint Server for Biology
|
June 12, 2025
Lack of synergy between AR targeted therapies and PARP inhibitors in homologous recombination-proficient prostate cancer
Nicole A Traphagen, Esmé Wheeler, Rong Li, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 33) with videos related to
Sort By:
Page
of 4
Current Opinion in Urology
|
March 21, 2013
Novel chemotherapies in development for management of castration-resistant prostate cancer
Alok K Tewari, Daniel J George
The Journal of Clinical Investigation
|
November 13, 2013
Type III TGF-β receptor promotes FGF2-mediated neuronal differentiation in neuroblastoma
Erik H Knelson, Angela L Gaviglio, Alok K Tewari, et al.
JAMA Oncology
|
June 2, 2017
Interventions to Improve Oral Chemotherapy Safety and Quality: A Systematic Review
Jessica A Zerillo, Benjamin A Goldenberg, Ritesh R Kotecha, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 18, 2009
Genomic strategy for targeting therapy in castration-resistant prostate cancer
Prateek Mendiratta, Elahe Mostaghel, Justin Guinney, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 14, 2026
How to Optimize Treatment for Patients With Poor-Risk Testicular Cancer
Noah Richardson, Alok K Tewari, Patrizia Giannatempo, et al.
Genome Research
|
May 24, 2022
Profiling the quantitative occupancy of myriad transcription factors across conditions by modeling chromatin accessibility data
Kaixuan Luo, Jianling Zhong, Alexias Safi, et al.
The Prostate
|
November 27, 2024
Personalized Medicine: Leave no Patient Behind; Report From the 2024 Coffey-Holden Prostate Cancer Academy Meeting
Andrea K Miyahira, Marina Sharifi, Lisa N Chesner, et al.
The Prostate
|
November 30, 2012
Resveratrol worsens survival in SCID mice with prostate cancer xenografts in a cell-line specific manner, through paradoxical effects on oncogenic pathways
Joseph C Klink, Alok K Tewari, Elizabeth M Masko, et al.
European Urology
|
July 1, 2008
Satisfaction and regret after open retropubic or robot-assisted laparoscopic radical prostatectomy
Florian R Schroeck, Tracey L Krupski, Leon Sun, et al.
Biorxiv : the Preprint Server for Biology
|
June 12, 2025
Lack of synergy between AR targeted therapies and PARP inhibitors in homologous recombination-proficient prostate cancer
Nicole A Traphagen, Esmé Wheeler, Rong Li, et al.
Page
of 4